back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-06-09 19:06 Tx date 2026-06-05 |
$VM
Voyageur Pharmaceuticals Ltd. |
McBeth, Kevin Richard
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+500,000 vol |
500,000 | |
| Filed 2026-06-09 19:06 Tx date 2023-07-20 |
$VM
Voyageur Pharmaceuticals Ltd. |
McBeth, Kevin Richard
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-06-09 19:06 Tx date 2026-06-05 |
$VM
Voyageur Pharmaceuticals Ltd. |
McBeth, Kevin Richard
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$50,000
+500,000 vol $0.10 each |
500,000 | |
| Filed 2026-06-09 19:05 Tx date 2023-07-20 |
$VM
Voyageur Pharmaceuticals Ltd. |
McBeth, Kevin Richard
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-06-09 19:04 Tx date 2026-06-05 |
$VM
Voyageur Pharmaceuticals Ltd. |
Shaw, Beth
4 - Director of Issuer
Holder: Fidelity Clearing Canada ULC ITF Beth Shaw (Indirect Ownership)
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+100,000 vol |
100,000 | |
| Filed 2026-06-09 19:04 Tx date 2025-04-30 |
$VM
Voyageur Pharmaceuticals Ltd. |
Shaw, Beth
4 - Director of Issuer
Holder: Fidelity Clearing Canada ULC ITF Beth Shaw (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-06-09 19:03 Tx date 2026-06-05 |
$VM
Voyageur Pharmaceuticals Ltd. |
Shaw, Beth
4 - Director of Issuer
Holder: Fidelity Clearing Canada ULC ITF Beth Shaw (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$10,000
+100,000 vol $0.10 each |
100,000 | |
| Filed 2026-06-09 19:03 Tx date 2025-04-30 |
$VM
Voyageur Pharmaceuticals Ltd. |
Shaw, Beth
4 - Director of Issuer
Holder: Fidelity Clearing Canada ULC ITF Beth Shaw (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-06-09 18:57 Tx date 2026-06-05 |
$VM
Voyageur Pharmaceuticals Ltd. |
Deslauriers, Albert Hill
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+100,000 vol |
100,000 | |
| Filed 2026-06-09 18:57 Tx date 2022-07-26 |
$VM
Voyageur Pharmaceuticals Ltd. |
Deslauriers, Albert Hill
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-06-09 18:57 Tx date 2026-06-05 |
$VM
Voyageur Pharmaceuticals Ltd. |
Deslauriers, Albert Hill
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$10,000
+100,000 vol $0.10 each |
100,000 | |
| Filed 2026-06-09 18:56 Tx date 2022-07-26 |
$VM
Voyageur Pharmaceuticals Ltd. |
Deslauriers, Albert Hill
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-06-09 18:11 Tx date 2026-06-05 |
$VM
Voyageur Pharmaceuticals Ltd. |
Fritzel, Eugene Leonard
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+200,000 vol |
200,000 | |
| Filed 2026-06-09 18:11 Tx date 2022-09-28 |
$VM
Voyageur Pharmaceuticals Ltd. |
Fritzel, Eugene Leonard
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-06-09 18:10 Tx date 2026-06-05 |
$VM
Voyageur Pharmaceuticals Ltd. |
Fritzel, Eugene Leonard
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$20,000
+200,000 vol $0.10 each |
232,250 | |
| Filed 2026-03-16 13:48 Tx date 2026-03-03 |
$VM
Voyageur Pharmaceuticals Ltd. |
Kraws, Jeffrey Jay
4 - Director of Issuer
Direct Ownership
|
Rights Deferred Share Unit
56 - Grant of rights
|
+16,367 vol |
16,367 | |
| Filed 2026-03-16 13:46 Tx date 2025-10-23 |
$VM
Voyageur Pharmaceuticals Ltd. |
Kraws, Jeffrey Jay
4 - Director of Issuer
Direct Ownership
|
Rights Deferred Share Unit
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-03-09 11:22 Tx date 2026-03-04 |
$VM
Voyageur Pharmaceuticals Ltd. |
Hashmi, Ibrahim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+150,000 vol |
450,000 | |
| Filed 2026-03-08 15:14 Tx date 2026-03-03 |
$VM
Voyageur Pharmaceuticals Ltd. |
Alling, Virginia Glasheen
4 - Director of Issuer
Direct Ownership
|
Rights Deferred Share Unit
56 - Grant of rights
|
+9,906 vol |
9,906 | |
| Filed 2026-03-08 15:13 Tx date 2025-11-05 |
$VM
Voyageur Pharmaceuticals Ltd. |
Alling, Virginia Glasheen
4 - Director of Issuer
Direct Ownership
|
Rights Deferred Share Unit
00 - Opening Balance-Initial SEDI Report
|